DermTech Inc (DermTech) is a genomics company that develops, manufactures and markets non-invasive precision dermatology solutions. It provides a melanoma test that non-invasively detects the presence of genomic markers associated with melanoma by identifying changes in the skin’s RNA (ribonucleic acid) and DNA (deoxyribonucleic acid). The company utilizes Smart Stickers to lift and collect skin cells from a suspicious skin spots. DermTech is also evaluating a Carcinome test to detect non-melanoma skin cancers; and a Luminate test, to identify UV (ultraviolet) damage. It utilizes precision biomarker platform technology for biomarker analysis of RNA, DNA, protein, and microbiome. It works in collaboration with genomics, medicine, biotechnology, and wellness companies. DermTech is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
12340 El Camino Real, San Diego, California, 92130
Telephone
1 858 4504222
No of Employees
278
Industry
Medical Equipment
Ticker Symbol & Exchange
DMTK (NASD)
Revenue (2022)
$15.3M
5.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
13.5%
(2022 vs 2021)
Market Cap*
$20.9M
Net Profit Margin (2022)
XYZ
17.9%
(2022 vs 2021)
* As of and is in US$
DermTech Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | Luminate |
| Carcinome Test | Smart Stickers |
| Luminate Test | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In April, the company announced an agreement with a physician-founded, member-focused and community-based not-for-profit health plan in New York or the foundational assay of Its DermTech melanoma test. |
| 2022 | Contracts/Agreements | In November, the company announced an agreement with Sonora Quest Laboratories to expand access to enhanced melanoma detection. |
| 2022 | New Products/Services | In April, the company announced the expansion of access to its telehealth application, DermTech Connect, from eight states to 44 states. |
Competitor Comparison
| Key Parameters | DermTech Inc | Leo Pharma AS | Castle Biosciences Inc | Caliber Imaging & Diagnostics Inc | MedX Health Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | Denmark | United States of America | United States of America | Canada |
| City | San Diego | Ballerup | Friendswood | Andover | Mississauga |
| State/Province | California | - | Texas | Massachusetts | Ontario |
| No. of Employees | 278 | 5,252 | 610 | 28 | - |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Matthew Posard | Chairman | Executive Board | 2019 | 56 |
| Bret Christensen | President; Chief Executive Officer; Director | Executive Board | 2023 | - |
| Kevin Sun | Secretary; Treasurer; Chief Financial Officer | Senior Management | 2019 | 45 |
| Claudia Ibarra | Chief Operating Officer | Senior Management | 2019 | 60 |
| Bill Zondler | Chief Information Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer